Respiratory Syrup in pharma franchise in Moradabad

Respiratory Syrup in PCD pharma franchise in Gurugram

Respiratory Syrup in top pharma company in Lucknow

Respiratory Syrup in pcd pharma supplier in Karnataka

Respiratory Syrup in phama franchise company in India
Respiratory Syrup in phama distributor in Bhopal

Home/Products /ambroxol-10mg-5ml-guaifenesin-25mg-5ml-terbutaline-0-point-5mg-5ml-syrup

Cufsniff AM Junior Syrup

Composition : Ambroxol (10mg/5ml) + Guaifenesin (25mg/5ml) + Terbutaline (0.5mg/5ml)

Dosage Form : Syrup

Packaging Type : With Carton & Measuring Cap

Packaging : 60ml

Price : ₹83/-

Cufsniff AM Junior Syrup is a pediatric formulation designed to provide comprehensive relief from respiratory conditions such as cough, chest congestion, and breathing difficulties. This balanced combination of three active ingredients works synergistically to address the underlying causes of respiratory discomfort. It belongs to the Cold and Cough therapy category and is classified under General medicines.

Cufsniff AM Junior Syrup contains:

  1. Ambroxol (10mg/5ml): A mucolytic agent that breaks down thick mucus, making it easier to expel. It improves airflow and alleviates chest congestion.
  2. Guaifenesin (25mg/5ml): An effective expectorant that helps thin and loosen mucus in the airways, facilitating productive coughing and improving respiratory function.
  3. Terbutaline (0.5mg/5ml): A bronchodilator that relaxes airway muscles, easing wheezing and difficulty in breathing caused by bronchospasm.

This combination is ideal for pediatric patients, providing a comprehensive approach to managing respiratory ailments by addressing mucus accumulation, airway constriction, and persistent cough.

Read More

About the Product

Cufsniff AM Junior Syrup is a pediatric formulation designed to provide comprehensive relief from respiratory conditions such as cough, chest congestion, and breathing difficulties. This balanced combination of three active ingredients works synergistically to address the underlying causes of respiratory discomfort. It belongs to the Cold and Cough therapy category and is classified under General medicines.

Cufsniff AM Junior Syrup contains:

  1. Ambroxol (10mg/5ml): A mucolytic agent that breaks down thick mucus, making it easier to expel. It improves airflow and alleviates chest congestion.
  2. Guaifenesin (25mg/5ml): An effective expectorant that helps thin and loosen mucus in the airways, facilitating productive coughing and improving respiratory function.
  3. Terbutaline (0.5mg/5ml): A bronchodilator that relaxes airway muscles, easing wheezing and difficulty in breathing caused by bronchospasm.

This combination is ideal for pediatric patients, providing a comprehensive approach to managing respiratory ailments by addressing mucus accumulation, airway constriction, and persistent cough.

Common side effects include: Mild stomach upset or nausea. Headache or dizziness. Diarrhea or dry mouth. Rare allergic reactions such as skin rash or itching. If side effects persist or worsen, seek medical advice promptly.

Cufsniff AM Junior Syrup is indicated for: Wet and productive coughs associated with conditions like asthma, bronchitis, and upper respiratory tract infections. Chest congestion due to excessive mucus production. Bronchospasm-related breathing difficulties.

Administer only as directed by a healthcare professional. Shake the bottle well before each use. Avoid using the syrup in children with known hypersensitivity to any of the ingredients. Discontinue use and consult a doctor if adverse effects occur or if symptoms worsen.

Store in a cool and dry place, away from direct sunlight. Keep out of reach of children. Do not refrigerate or freeze the syrup.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation